These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [A case of total regression of endometrial carcinoma metastases in the lung under hormonal therapy (author's transl)]. Caminati M; Hauser GA Ther Umsch; 1979 Jun; 36(6):516-7. PubMed ID: 462406 [No Abstract] [Full Text] [Related]
24. [Effects of progesterone on DNA synthesis by human endometrial carcinoma cells in vitro]. Bloch L; Stein JA Harefuah; 1972 Dec; 83(12):543-6. PubMed ID: 4659022 [No Abstract] [Full Text] [Related]
25. Progesterone caproate in the treatment of endometrial cancer. Sherman AI Obstet Gynecol; 1966 Sep; 28(3):309-14. PubMed ID: 4162030 [No Abstract] [Full Text] [Related]
26. Observation on DNA synthesis of cancer cells in gestagen treatment of endometrial carcinoma. Sugawa T; Moriyama I; Kakita M; Shiba S; Shimamoto T Acta Obstet Gynaecol Jpn; 1970 Jan; 17(1):25-30. PubMed ID: 5467430 [No Abstract] [Full Text] [Related]
27. [Use of 17-alpha-hydroxprogesterone-capronate in certain malignant tumors]. Garin AM; Voznyĭ EK; Borisov VI; Dobrushina VA; Lazovskaia EB Klin Med (Mosk); 1974 Mar; 52(3):121-3. PubMed ID: 4466932 [No Abstract] [Full Text] [Related]
28. [The role of hormone therapy in the treatment of cancer of the endometrium]. Vekhova LI; Shuvaeva NI; Malysheva SF; Lebedeva AV Vopr Onkol; 1983; 29(3):26-30. PubMed ID: 6836983 [TBL] [Abstract][Full Text] [Related]
29. [Effects of medroxyprogesterone (MAP) therapy on the DNA content in adenocarcinoma of the human endometrium]. Vecchietti G; Gerzeli G; Zanoio L; Novelli GG; Barni S Minerva Ginecol; 1979; 31(7-8):597-603. PubMed ID: 481819 [No Abstract] [Full Text] [Related]
30. [Effect of long-term progestational treatment on the course of endometrial adenocarcinoma]. Szarvas Z Morphol Igazsagugyi Orv Sz; 1978 Jul; 18(3):166-73. PubMed ID: 714054 [TBL] [Abstract][Full Text] [Related]
31. [Action of 17-hydroxyprogesterone caproate on the glandular hyperplasia of human endometrium]. Lukina EL; Prianishnikov VA Arkh Patol; 1978; 40(3):45-50. PubMed ID: 646674 [TBL] [Abstract][Full Text] [Related]
33. [Basis of gestagen therapy of endometrial carcinoma]. Trams G Dtsch Med Wochenschr; 1978 Mar; 103(13):574-7. PubMed ID: 639688 [No Abstract] [Full Text] [Related]
34. [Hormofort in the treatment of metastatic adenocarcinoma of corpus uteri]. Kaliński R; Wlodarski A Wiad Lek; 1972 Oct; 25(20):1903-5. PubMed ID: 4643245 [No Abstract] [Full Text] [Related]
35. [Treatment of carcinoma corporis uteri using progesterone]. Igel H Zentralbl Gynakol; 1972 Aug; 94(33):1084-7. PubMed ID: 4116922 [No Abstract] [Full Text] [Related]
36. [Description of some cases of mammary and uterine carcinoma treated with hydroxyprogesterone capronate]. Barnaba T Minerva Ginecol; 1970 Oct; 22(19):957-63. PubMed ID: 5515156 [No Abstract] [Full Text] [Related]
37. [Hormonotherapy of the recurrent carcinoma of the uterus]. Graham R; Graham J; Hreshchyshyn M; Ross A Gynecol Prat; 1967; 18(6):591-5. PubMed ID: 5621518 [No Abstract] [Full Text] [Related]
38. [Regularities and paradoxes of endocrine dependence and hormonal therapy of endometrial cancer]. Bokhman IaV; Volkova AT; Chepik OF; Vishnevskiĭ AS Vopr Onkol; 1990; 36(11):1382-8. PubMed ID: 2281650 [No Abstract] [Full Text] [Related]
39. Endometrial cancer as an estrogen-progesterone target. Richardson GS N Engl J Med; 1972 Mar; 286(12):645-7. PubMed ID: 4551276 [No Abstract] [Full Text] [Related]